Abstract This is a secondary analysis of data from a randomized trial of dually-focused interventions for nonadherent HIV patients with cocaine use disorders (Ingersoll et al. in Drug Alcohol Depend 116(1-3):177-187, 2011). We examined the relationships among baseline demographic, psychological, psychiatric, and behavioral characteristics and 6-months post-study ART adherence, log viral load (VL), ASI Drug Composite Score, and days using cocaine. We used the SAS GLMSELECT procedure to build multivariate models of each post-study outcome. Post-study ART adherence was related to 2 psychological variables; while logVL was related to 2 drug-related behaviors. ASI Drug Composite score was related to 2 psychiatric disorders, 1 demographic, and 1 psychological variable; in contrast, days using cocaine related to 1 behavioral and 3 psychological variables. Analyses show clear, robust relationships among behavioral, psychological and psychiatric diagnosis factors with post-study ART adherence and cocaine use outcomes. Future ART adherence interventions for cocaine users should consider tailoring to these patient characteristics.
Introduction
Adherence to antiretroviral therapy (ART) medications must be nearly perfect to prolong health and to avoid treatment failure, although emerging evidence suggests that some newer ART regimens may allow for slightly more nonadherence [3, [20] [21] [22] 30] . Poor adherence to HAART and frequent drug use each contribute to faster progression of disease, morbidity, and mortality [4, 16, 17] .
Crack cocaine use has a particularly negative effect on ART adherence [2, 12, 14, 15, 25] . Crack cocaine use is an independent predictor of running out of HIV medications [12] . The binge consumption pattern typical of crack cocaine use can lead to the suspension of medication dosing during seeking, using, and recovery from the drug [10] . In addition to its negative effects on adherence, cocaine use itself is independently associated with HIV acceleration and disease progression [4, 6] . Cocaine users often enter HIV treatment in more advanced states of disease [5, 31] , making them more vulnerable to poor treatment outcomes and associated morbidity and mortality [32] .
Efforts to improve adherence to HIV medication regimens began with the advent of ART in 1996. Many studies have tested combination interventions that include counseling, reminders, and strategies to help nonadherent patients achieve and maintain adherence. Unfortunately, behavioral interventions have modest and ephemeral effects and frequently do not result in high adherence, even when theory-based and well-executed [1, 8, 11, 23, 24, 28] . Most adherence studies have excluded active substance users, although, arguably, this is a high risk subpopulation in particular need of intervention. There is an urgent need for more potent and durable ART adherence interventions for street drug users to achieve critical benchmarks on the HIV care cascade [9] .
To address this gap, we compared two interventions targeting both adherence and drug use, based on the Information-Motivation-Behavioral Skill model of ART adherence [7] . The pilot study was conducted from 2004 to 2009 in two cities in central Virginia. Participants were recruited from infectious disease clinics using flyers, clinician referral, and direct approach. English-speaking HIV positive adults with current crack cocaine use or a crack cocaine use disorder (abuse or dependence) and less than 90 % self-reported adherence to a current prescription for ART over the preceding 14 days were eligible to participate. After informed consent, participants completed interviews and self-report measures, and provided urine, blood samples, and vital signs to assess drug use, VL, CD4 count, blood pressure, and pulse rate. They were randomized to a 6-session Motivational Interviewing plus Feedback intervention or to a 6-session informational video plus debriefing intervention. Follow-ups occurred at weeks 12 (post-treatment) and 24 (6 month follow-up). Participants were 54 patients in HIV care. Analyses of outcomes data showed that both interventions improved ART adherence and cocaine-related problems durably. Significant increases in ART adherence and reductions in ASI Drug Composite Scores occurred in both conditions by post-treatment and were maintained at 6 months, representing medium effect sizes. No between-group differences were observed, and no VL changes were observed in either group [13] . Both interventions improved cocaine use and ART adherence, with good maintenance of changes among previously nonadherent crack cocaine users.
The purpose of this report is to explore which participant characteristics related to post-study outcome variables. We hypothesized that patient characteristics drove behavior change, given that the study found moderate effects, but these did not differ between intervention conditions. Therefore, this study is a secondary, exploratory analysis of the pilot study data to determine which patient characteristics related to 4 important post-study outcomes. This information may help us to better specify the elements that may influence outcome. By attending to them in future interventions, we may tailor and improve dually-focused interventions that target nonadherence and substance use disorders. Refining interventions may increase their potency and durability, and could help to further specify models of ART adherence interventions.
Methods

Measures
The parent study measured demographics and patient characteristics including age, sex, race, ethnicity, education, employment, sexual orientation, and criminal justice involvement. It measured health variables including lifetime HIV risk behaviors, years since HIV diagnosis, immune health status, and comorbid health conditions. It measured cocaine and alcohol use, abuse and dependence, and comorbid psychiatric disorders with the Mini International Neuropsychiatric Interview (M.I.N.I.) [26, 27] . In the parent study, mean 14-day ART adherence (defined as the percent of prescribed pills taken) was assessed using the timeline follow-back (TLFB) method [29] . logVL was another marker of ART adherence. Drug use outcomes included cocaine-specific drug composite scores calculated from the ASI, a brief semi-structured interview with accepted reliability and validity for assessing the existence, duration, and severity of substance-use-related problems in seven areas (drug, alcohol, medical, employment, legal, family/social, and psychiatric problems) over the previous 30 days [19] . ASI drug composite scores can show change in drug use problems over time, and offer an internally consistent estimate of drug use problems, with higher scores reflecting more problems related to drug use [18] . A secondary measure of cocaine use was the percent of days using crack cocaine, calculated from self-reports of use on each day on the 14-day TLFB.
Candidate Characteristics
The potential explanatory characteristics used for the current study were chosen because of their relationships with substance abuse and/or ART adherence established in the literature. We selected baseline participant characteristics that could be related to study outcomes at the 6 month follow-up (ASI Cocaine Composite Score, Cocaine Days, ART Adherence, and logVL) based on this literature. In general, these include demographic, health behaviors, psychiatric disorders, and substance use disorders. Additionally, we were interested in psychological variables that could influence ART adherence or cocaine use. Our goal was to identify characteristics that related to improving ART adherence and/or decreasing cocaine use in order to identify either targets for tailoring interventions, or to identify potential content areas for future interventions.
Data Analysis
We used descriptive statistics, t tests, and Chi square tests to characterize the sample. Our approach was to first examine the univariate relationships between the set of candidate patient characteristics and each outcome variable at the 6 month follow-up (6 M). We dropped all variables in each set that were not significantly related to the 6 M outcome variable. To further reduce the variable set, we excluded variables that measured overlapping constructs and selected only the most important phenotype. For example, if three different markers of depression were related to an outcome, we selected current major depressive disorder (MDD) rather than dysthymia or lifetime MDD. We generated multivariate models of each outcome using the SAS GLMSELECT procedure. This procedure utilizes stepwise model testing, and allows for the inclusion of both continuous and categorical explanatory variables. We specified that only those explanatory variables with relationships to the outcome whose significance values were 0.1 or less should be retained in the model. Once models were developed, we examined the nature and direction of relationships between each characteristic and the related outcome through correlation analysis.
Results
Participants
Sample characteristics are shown in Tables 1, 2 , and 3. In brief, at baseline the sample of 54 participants was about half female, mostly African-American, unemployed, heterosexual people with at least a high school education. Most participants had detectable viral loads and CD4 counts indicating compromised immune systems. ART adherence over the past 14 days on the TLFB was 58 % on average. Participants used cocaine on a third of days on the TLFB, with half positive for cocaine on urine screen at study entry. The most common psychiatric conditions identified by the MINI were Cocaine Dependence (92.3 %), current MDD (48.1 %) and current Generalized Anxiety Disorder (30.8 %). All participants had one or more psychiatric diagnoses on the MINI.
In terms of psychological characteristics, participants showed a normal range of personality traits on the NEO-FFI. They were interpersonally submissive, with strong warm/friendly characteristics on the Inventory of Interpersonal problems. They reported low to average social support on the MOS Social Support Scale and moderate treatment motivation on the treatment motivation scale. Self-efficacy was measured in terms of temptation for nonadherence and confidence for adherence, and temptation for cocaine use and confidence to refrain from cocain use. Self-efficacy for ART adherence showed higher confidence to adherence than temptation for nonadherence. In contrast, self-efficacy for cocaine use was lower, with temptation to use cocaine exceeding confidence to refrain from cocaine use. A majority of participants was classified in the preparation stage of change for cocaine use (88.9 %) and medication adherence (40.7 %). Participants reported using a range of processes of change for cocaine use, but used action-oriented strategies like reinforcement management and stimulus control less than strategies consistent with contemplation like consciousness raising, self-liberation, and self-reevaluation. In general, participants reported higher use of more strategies for ART adherence. On visual analog scales (0-100) for their perceived importance, confidence, and readiness to change cocaine use or ART adherence, participants rated all three higher for ART adherence than for cocaine use. On the Self-Regulation Questionnaire, their scores were consistent with average levels of self-regulation, with highest scores on the Search and Instigation to Change subscales. Table 4 presents the relationships between participant characteristics and each 6 M outcome. Characteristics related to ASI drug composite score at 6 M included demographic variables, psychological variables, psychiatric disorders and drug use variables. Characteristics related to days using cocaine at 6 M included one demographic variable, psychological variables, a psychiatric disorder, drug use variables, and a health indicator, CD4 count. Characteristics related to ART adherence at 6 M included demographics, psychological variables, and psychiatric disorders. Characteristics related to log viral load at 6 M included health variables, psychological variables, psychiatric variables, and drug variables. Table 5 presents the final multivariate models.
Relationships of Participant Characteristics and Outcomes
Characteristics Related to Cocaine Use Outcomes
The model of ASI Cocaine Composite score was significant (F (5, 26 df) = 5.38; p,0.01) and explained 50.87 % of the variance. Significant characteristics and their correlations with the outcome (shown in Supplementary Table 1) were MDD current (r = 0.40, p \ 0.05), temptation for ART nonadherence (r = 0.32, p \ 0.05), Homicidality (no correlation calculated), and age (r = 0.32, p \ 10). NEO Openness was retained in the model but was not independently related to outcome.
The model of days using cocaine was significant (F (4, 33 df) = 8.01; p \ 0.001) and explained 49.25 % of the variance. Participant characteristics that related to this outcome included NEO-FFI Conscientiousness (r = -0.27, p \ 0.10), readiness to change cocaine use (r = -0.31, p \ 0.05), confidence to change ART adherence (r = 0.26, p \ 0.10), and negative urine toxicology for cocaine at study entry (correlation not calculated).
Participant Characteristics Related to ART Adherence Outcomes
The model of ART adherence was significant (F (2, 36 df) = 9.29; p \ 0.001) and explained 34.04 % of the variance. Participant characteristics that related to this outcome included desire for help on the Treatment Motivation Scale (r = 0.43, p \ 0.01), and self-regulation total score (r = 0.30, p \ 0.10).
The model of logVL was significant (F (2, 22 df) = 3.51*) and explained 24.19 % of the variance. Participant characteristics related to this outcome included ASI alcohol composite score (r = -0.10, ns) and a negative toxicology screen for marijuana (correlation not calculated). 
Discussion
This secondary analysis of data from a trial that compared two behavioral interventions targeting both ART adherence and cocaine use found that different sets of participant characteristics were related to post-study ART adherence and cocaine use outcomes. Behavioral, psychological, and psychiatric diagnosis variables were independently related to outcomes, and explained a large proportion of the variance. In general, the models of cocaine use outcomes Full sample is the sample at baseline when 2 mistaken enrollments were removed. Completers sample at baseline is the sample completing the 6 month follow-up (6 M). Completers sample at 6 M is the values re-measured at 6 months after baseline. Some n's are lower than the full sample due to missing data for that variable. Some percentages do not total to 100 % due to rounding, or due to responses such as ''refused'' or ''don't know,'' (data not shown) a While a full drug panel was collected, no participants were positive for drugs other than those shown accounted for more variance than the models of ART adherence outcomes.
Understanding Drug Use Outcomes
Age, current MDD, and Temptation not to adhere to ART regimens were significantly related to ASI Cocaine Composite scores at the 6 month follow-up. These relationships may occur for several reasons. Age could be related to both treatment-seeking for drug use problems, and recognition of the problems the person has related to cocaine use, both potentially increasing response to the intervention. Struggling with depression may have been related to cocaine ''crashes'' (experiencing a range of negative mood and psychological symptoms related to cocaine withdrawal) and could have also served as a motivator for treatment. It is less clear why being tempted NOT to adhere to HIV medications predicts cocaine use outcomes, but it is common for HIV patients who use street drugs to view them as dangerous to mix with medications. Thus, the temptation not to adhere to ART may represent their tendency to skip medications when using cocaine and other street drugs due to this belief. Alternatively, ART medications may have been viewed as lower in importance than obtaining substance abuse treatment. Different characteristics related to days using cocaine at the 6 month follow-up. Both readiness to change cocaine use and conscientiousness were significantly inversely related to days using cocaine, meaning that more conscientious people and those with higher levels of readiness to change their cocaine use had fewer days using cocaine at the 6 month follow-up. Higher conscientiousness and readiness may have meant that people were willing to work harder to eliminate cocaine use habits. Participants with negative urine toxicology screens for cocaine at baseline also had fewer days using cocaine at follow-up. These people may have already begun changing their cocaine use behavior, compared to those who provided cocaine-positive urine samples at baseline. In contrast, higher confidence about ART adherence related to more days using cocaine at follow-up. It is possible that this subset of the sample was more focused on HIV treatment than substance abuse treatment.
Understanding ART Adherence Outcomes
Two psychological characteristics composed the multivariate model of ART adherence. Patients' baseline desire for help with cocaine-related problems was significantly directly related to ART adherence at follow-up, while selfregulation total score was correlated to ART adherence at a trend level. These variables could have increased the person's engagement in the intervention, and their efficacy to enact recommended changes.
The model of logVL at 6 month follow-up included only two patient characteristics, both related to cocaine use behaviors. Alcohol composite scores and Marijuana-negative urine screens were both inversely related to logVL at Full sample is the sample at baseline when 2 mistaken enrollments were removed. Completers sample at baseline is the sample completing the 6 month follow-up (6 M). Some n's are lower than the full sample due to missing data for that variable. Some percentages do not total to 100 % due to rounding, or due to responses such as ''refused'' or ''don't know,'' (data not shown) D/O is Disorder, MDD is Major depressive disorder, OCD is obsessive compulsive disorder, PTSD is Post traumatic stress disorder ? p \ 0.1; * p \ 0.05; ** p \ 0.01; *** p \ 0.001 Baseline characteristics with univariate relationships to cocaine days at 6 M n Mean (SD) Test
Continuous variables
Proportion of days in 90 using cocaine 6 M, meaning that higher baseline problems from drinking and the absence of marijuana in urine samples were related to better logVL at follow-up. These results are difficult to explain because they imply that drinking problems but the absence of current marijuana use are both related to improved (lower) levels of HIV in the blood. The relationship between ART adherence and viral load is not necessarily direct or linear. Perhaps it is not surprising that psychological factors influence taking ART medication, while cocaine use behaviors are related to a direct clinical marker of immune health.
Limitations and Strengths
This study is exploratory in nature, and intended to identify promising targets for development of future interventions focused on cocaine use and ART adherence. This study used data from a small sample from a pilot dual-focused study, and the results from a stepwise model building method could over-estimate the relationships between explanatory variables and outcomes. The findings are specific to crack cocaine users, and may not apply to HIV patients who use other types of street drugs. Further investigations of the importance and patterns of the relationships between the participant characteristics that related to cocaine use and ART adherence outcomes in this study are needed. We modelled characteristics that related to 4 different markers of outcome, including self-reports of Art adherence and cocaine use on the TLFB. It could be argued that only biological or objective markers of outcomes or benchmarks on the HIV care cascade are important. However, to move the ART adherence intervention field forward, a better understanding of the characteristics that relate to the most common types of outcome measures is needed.
This analysis also has strengths. It identified an intriguing set of participant characteristics that influenced ART adherence and cocaine use outcomes for patients with HIV who use cocaine. While the sample size was small in the parent study, the follow-up rate was excellent, yielding a representative sample at the 6 month follow-up point.
Clinical Implications
How can these findings help to develop tailored, more effective ART adherence interventions for people who use cocaine and are living with HIV? We were unable to find a previous study that tailored interventions to specific patient characteristics to improve their potency or lengthen their duration of impact. Therefore, we stick closely to these exploratory findings and their potential implications for intervention development.
The tested interventions targeting both cocaine use and ART adherence reduced drug-related problems among older, depressed patients with beliefs that they should skip HIV medications when using drugs. The idea that ART should be skipped during periods of drug use is common, and more education about this within interventions is indicated. When dealing with younger patients, with less awareness of cocaine-related problems, or those who are not depressed, interventions that raise consciousness or even increase their distress about cocaine use may be needed. Additionally, the interventions worked well to decrease cocaine-using days for those ready to change, and those who have already started to change. More motivational components in interventions may be required for cocaine-using patients with lower readiness, lower levels of conscientiousness, and who present for treatment with cocaine-positive urines. Additionally, these findings imply that interventions that build skills in self-regulation or increase the desire for help as a motivation for treatment could enhance ART adherence outcomes.
Conclusions
In this exploratory study of a small sample of cocaine users who were nonadherent to ART treatment, we identified characteristics that related to drug use and ART adherence outcomes at the 6 month follow-up. The relationship found among psychiatric, psychological, and behavioral variables and cocaine-related problems (and days using cocaine) at 6 M fits with the literature. In general, those who were older, depressed, and tempted to skip HIV medications had In some instances degrees of freedom does not match the full completers sample at baseline due to missing responses at the 6-month follow-up (6 M) ? p \ 0.1; * p \ 0.05; ** p \ 0.01; *** p \ 0.001 fewer problems related to cocaine use at 6 M. There was also a logical relationship between psychological traits like conscientious, constructs like readiness to change cocaine use, behaviors like beginning to reduce cocaine use (as evidenced by a cocaine-negative screen), and days using cocaine at 6 M. Similarly, there were logical relationships between psychological variables such as being motivated for treatment by a desire for help and higher use of self-regulation skills and the behavior of taking ART medications. In contrast, the reason for the relationships between drug use behaviors and logVL is less clear and should be studied further.
We recommend that future dual-focused interventions contain content and intervention processes that are tailored to the behavioral, psychological, and psychiatric characteristics that related to cocaine use and ART adherence outcomes. Overall, these results suggest a potential benefit of adding information on myths such as avoiding ART during cocaine use, along with self-regulation and motivational strategies, to future interventions targeting both ART adherence and cocaine use. These findings may help to extend and further specify the Information-MotivationBehavioral Skills model of ART adherence. 
